Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic tranexamic acid for reducing blood loss at caesarean section in women at high risk of postpartum haemorrhage
PACTR202603864365244Phase 2Not yet recruiting
- Sponsor
- Ezugwu Ifeanyi Anthony
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic acid prophylaxis with Placebo (2 arms). Primary endpoint: Mean intra-operative blood loss during caesarean delivery. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202603864365244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603864365244.